Claims
- 1. A pharmaceutical composition in dosage unit form which comprises a dosage of p-aminobenzoic acid-N-L-rhamnoside or pharmaceutically acceptable salt thereof effective for the treatment of a tumor growth.
- 2. A pharmaceutical composition of claim 1 which is in the form of said pharmaceutically acceptable salt which is the sodium salt.
- 3. A pharmaceutical composition in oral dosage unit form which comprises a dosage of p-aminobenzoic acid-N-L-rhamnoside or pharmaceutically acceptable salt thereof effective for the treatment of a tumor growth.
- 4. A pharmaceutical composition of claim 3 which is in the form of said pharmaceutically acceptable salt which is the sodium salt.
- 5. A pharmaceutical composition in parenteral dosage unit form which comprises a dosage of p-aminobenzoic acid-N-L-rhamnoside or pharmaceutically acceptable salt thereof effective for the treatment of a tumor growth.
- 6. A pharmaceutical composition of claim 5 which is in the form of said pharmaceutically acceptable salt which is the sodium salt.
Parent Case Info
This application is a continuation of Ser. No. 484,592, filed Apr. 13, 1983, now U.S. Pat. No. 4,559,327, which is a continuation-in-part of Ser. No. 289,226, filed Aug. 3, 1981, now abandoned, which is a divisional of Ser. No. 102,535, filed Dec. 11, 1979, U.S. Pat. No. 4,313,939, which is a continuation-in-part of Ser. No. 039,218, filed May 15, 1979, now abandoned.
US Referenced Citations (12)
Non-Patent Literature Citations (4)
Entry |
Chem. Abstracts, vol. 92 (1980) p. 94677(a). |
Chem. Abstracts, vol. 69 No. 1 (1968) p. 1022, 106287. |
Chem. Abstracts, vol. 48: 2001-2003. |
Johnson et al., "Cancer Treatment Reviews", 1975, vol. 2, pp. 1-6. |
Divisions (1)
|
Number |
Date |
Country |
Parent |
102535 |
Dec 1979 |
|
Continuations (1)
|
Number |
Date |
Country |
Parent |
484592 |
Apr 1983 |
|
Continuation in Parts (2)
|
Number |
Date |
Country |
Parent |
289226 |
Aug 1981 |
|
Parent |
39218 |
May 1979 |
|